The paraphilias and Depo-Provera: some medical, ethical and legal considerations.
Paraphilic disorders are Axis I psychiatric afflictions. They are not acquired by volitional decision, but are manifested by the association of erotic arousal with unacceptable behavior or stimulae (e.g., children). Because paraphilic behavior occurs in the service of a biological drive, use of medication to suppress sexual appetite may constitute an adjunct in treatment. Medroxyprogesterone can be used to decrease unacceptable erotic urges and fantasies, with the intent of increasing self-control. Such treatment should not be forced upon an unwilling person. Conversely, persons should not be denied access to treatment by laws which deter seeking help, or because of incarceration, parole, or probation.
Berlin
F S
FS
Johns Hopkins Hospital, Baltimore, Maryland.
D000726:Androgen Antagonists / Q000627:therapeutic use*; D032763:Behavior Control; D003219:Confidentiality / Q000331:legislation & jurisprudence; D004989:Ethics; D006801:Humans; D035846:Law Enforcement; D008297:Male; D037141:Mandatory Programs; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D028642:Persons with Psychiatric Disorders; D010262:Paraphilic Disorders / Q000188:drug therapy*; D010344:Patient Advocacy / Q000331:legislation & jurisprudence; D028701:Patient Rights; D018570:Risk Assessment; D014481:United States; D035141:Voluntary Programs
D000726:Androgen Antagonists; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone